Page last updated: 2024-08-23

cabergoline and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone

cabergoline has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cong, Z; Luo, X; Ma, C; Sun, R; Tang, C; Wen, G; Yang, J; Zhong, C; Zhu, J1

Other Studies

1 other study(ies) available for cabergoline and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone

ArticleYear
Bromocriptine and cabergoline induce cell death in prolactinoma cells via the ERK/EGR1 and AKT/mTOR pathway respectively.
    Cell death & disease, 2019, 04-18, Volume: 10, Issue:5

    Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Bromocriptine; Cabergoline; Cell Line, Tumor; Early Growth Response Protein 1; Extracellular Signal-Regulated MAP Kinases; Female; Mice; Mice, Nude; Microtubule-Associated Proteins; Pituitary Neoplasms; Prolactinoma; Proto-Oncogene Proteins c-akt; Rats; RNA Interference; RNA, Small Interfering; Signal Transduction; TOR Serine-Threonine Kinases

2019